High-risk groups The flu can cause serious complications to anyone. Certain groups are at a higher risk. People in contact with high-risk individuals should be vaccinated as well. AETNA BETTER HEALTH | Proprietary and Confidential 1 Aetna Inc.
Complications Children and the elderly are more susceptible to complications: • Pneumonia • Bronchitis • Sinus and ear infections • Chronic conditions made worse from the flu AETNA BETTER HEALTH | Proprietary and Confidential 2 Aetna Inc.
Medication treatment Get vaccinated Supportive Care Anti-viral medication • Anti-pyretics (acetaminophen, • Check your seasonal CDC influenza ibuprofen) website for recommended FDA- approved medications • Hydration by mouth or through IV AETNA BETTER HEALTH | Proprietary and Confidential 3 Aetna Inc.
Recommend Documents
Diabetes prevention in high-risk ethnic groups Dr Thomas Yates Professor in
Groups at Risk of Negative Returns to Education Investment Nick Hillman
Overall cure rate not improved Failure of secondary prevention strategies
Identifying and Treating Your High Risk Patient Population Beth Hickerson
Risk estimation in high- risk patients . . in everybody!? Nationale
Do informal risk-sharing groups reduce the challenge of providing
Transition of Current Programs for High-Risk Pregnancy and At-Risk Children
CORONA VIRUS PREPARATIONS CORONA VIRUS - LATEST The risk to healthy school
Research Questions How m uch risk contracting is really out there? Risk
Turin, Sept 13-14, 2018 How I treat high risk Waldenstrms Macroglobulinemia?
Enhancing Opioid Stewardship Among Surgeons Tudor Borza, MD, MS SCW Member
Intracranial Pressure (ICP) Causes, Concerns and Management The Neurosurgery
Chief Medical Examiners Death Review A component of the CPSM Prescribing
Non-opiate Alternatives for Treating Acute Pain in the Emergency Department
PERI-OPERATIVE MULTIMODAL ANALGESIA Inadequate Postoperative pain relief can
Acute Pain Management in the Hospital Setting Alexandra Phan, PharmD PGY-1
2018 www.pccds-ln.org The Uses of CDS in the Opioid Crisis Chris Harle, PhD
EMA/EU-FDA Activity Update Vada A. Perkins HL7 SPL(R7) Publication HL7
CANCER IMMUNOTHERAPY 2018 Presented by John A Keech Jr DO MultiCare Regional
A U G U S T 2 9 , 2 0 1 9 ANF Presentation Presentation Overview Clinical
Northwestern University Feinberg School of Medicine Take, Wait, Stop:
Color orado A o ALTO P Project Pharmacy Training Pharmacy Training